MedTrace Logo

Expanded Access - Autologous Human Schwann Cells in Peripheral Nerve Repair

NCT04465929 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2020-07-10

No results posted yet for this study

Summary

Emergency expanded access for a single patient was granted to receive autologous human Schwann cell (ahSC) augmentation of nerve autograft repair after severe peripheral nerve injury (PNI).

Conditions

  • Peripheral Nerve Injuries

Interventions

BIOLOGICAL

Autologous Human Schwann Cells

Schwann cells harvested from the sural nerve and debrided, injured sciatic nerve of the participant will be autologously transplanted along sural nerve autografts wrapped in a collagen matrix

Sponsors & Collaborators

  • W. Dalton Dietrich

    lead OTHER

Principal Investigators

  • Allan D. Levi, MD, PhD · University of Miami

Eligibility

Min Age
16 Years
Max Age
16 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04465929 on ClinicalTrials.gov